BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12879449)

  • 1. Cooperative interactions between epigenetic modifications and their function in the regulation of chromosome architecture.
    Weissmann F; Lyko F
    Bioessays; 2003 Aug; 25(8):792-7. PubMed ID: 12879449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulators and histone modification.
    Imhof A
    Brief Funct Genomic Proteomic; 2006 Sep; 5(3):222-7. PubMed ID: 16951415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of epigenetic inheritance.
    Martin C; Zhang Y
    Curr Opin Cell Biol; 2007 Jun; 19(3):266-72. PubMed ID: 17466502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
    Vaissière T; Sawan C; Herceg Z
    Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epigenetics and cancer].
    Deltour S; Chopin V; Leprince D
    Med Sci (Paris); 2005 Apr; 21(4):405-11. PubMed ID: 15811306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics, stability and inheritance of somatic DNA methylation imprints.
    Sontag LB; Lorincz MC; Georg Luebeck E
    J Theor Biol; 2006 Oct; 242(4):890-9. PubMed ID: 16806276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of disease: epigenesis.
    Waggoner D
    Semin Pediatr Neurol; 2007 Mar; 14(1):7-14. PubMed ID: 17331879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic inheritance in plants.
    Henderson IR; Jacobsen SE
    Nature; 2007 May; 447(7143):418-24. PubMed ID: 17522675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recursive causality in evolution: a model for epigenetic mechanisms in cancer development.
    Haslberger A; Varga F; Karlic H
    Med Hypotheses; 2006; 67(6):1448-54. PubMed ID: 16844314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology.
    Csoka AB; Szyf M
    Med Hypotheses; 2009 Nov; 73(5):770-80. PubMed ID: 19501473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational epigenetics.
    Bock C; Lengauer T
    Bioinformatics; 2008 Jan; 24(1):1-10. PubMed ID: 18024971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic patterns of DNA methylation: targets and function of an epigenetic mark.
    Weber M; Schübeler D
    Curr Opin Cell Biol; 2007 Jun; 19(3):273-80. PubMed ID: 17466503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band.
    Frigola J; Song J; Stirzaker C; Hinshelwood RA; Peinado MA; Clark SJ
    Nat Genet; 2006 May; 38(5):540-9. PubMed ID: 16642018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation as a regulatory mechanism for gene expression in mammals.
    Serman A; Vlahović M; Serman L; Bulić-Jakus F
    Coll Antropol; 2006 Sep; 30(3):665-71. PubMed ID: 17058541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic imprinting and methylation: epigenetic canalization and conflict.
    Wilkins JF
    Trends Genet; 2005 Jun; 21(6):356-65. PubMed ID: 15922835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in epigenetic modifications during oocyte growth in mice.
    Kageyama S; Liu H; Kaneko N; Ooga M; Nagata M; Aoki F
    Reproduction; 2007 Jan; 133(1):85-94. PubMed ID: 17244735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies.
    Bhalla KN
    J Clin Oncol; 2005 Jun; 23(17):3971-93. PubMed ID: 15897549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of mammalian DNA methyltransferases in the regulation of gene expression.
    Turek-Plewa J; Jagodziński PP
    Cell Mol Biol Lett; 2005; 10(4):631-47. PubMed ID: 16341272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.